The Italian startup that doubles the lifecycle of heart valves (Fortune)

«Our company BCI has entered into negotiations with the two main industrial partners in the field of biological heart valves – in terms of sales volume» declared Alessandro Gandaglia, CEO of BCI to Fortune.

The greatest benefits of the FACTA Technology developed by BCI are the reduction by 20-30% of the valve replacement surgeries and its consequent decrease of health care expenses.